Clinical trial
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
NCT00382824 is registered in ClinicalTrials.gov with Lahey Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
- Lead sponsor
- Lahey Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- January 31, 2015
- Enrollment
- 61 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
progressive supranuclear palsy